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Structural chromosomal abnormalitiesa b s t r a c t
Background: Global developmental delay (GDD) represents a measurable lag in a young child’s achieve-
ment of developmental milestones compared to age matched children. Affection of two or more develop-
mental domains is fundamental for assumption of GDD. Many chromosomal abnormalities are
responsible for developmental delay or mental retardation and can be detected using G-banded kary-
otyping.
Aim of the work: This work aimed to determine the yield of karyotyping in children with GDD and/or dys-
morphic features in Sohag University Hospital, Upper Egypt.
Subjects and methods: All children presenting with GDD and/or dysmorphic features, with abnormal kary-
otyping or other genetic testing were included. Full history, thorough clinical and detailed neurological
examinations were done. The results of other investigations done for the patients, including neuroimag-
ing and electroencephalography (EEG), were utilized (if available).
Results: The total number of patients included was 395 patients, out of 646 patients who did karyotype;
the mean age of presentation was 24.7 ± 32.1 (SD) months, there were 243 (61.5%) males and 152 (38.5%)
females. The positive yield of karyotyping in children with developmental delay and/or dysmorphic fea-
tures, including classic Down features, was 61.1%; however, with exclusion of Down syndrome and other
suspected trisomies, it became 7.4%. The most prevalent chromosomal abnormality was trisomy 21-
Down syndrome (364 patients/92.2%), followed by structural chromosomal abnormalities and marker
chromosome in 19 patients (4.8%) and, lastly, sex chromosome abnormalities (8 patients/2.0 %). The main
complaint was GDD in half of the patients (205/51.9%), while the majority of patients had microcephaly.
Conclusion: G-banded karyotyping is a useful tool with reasonable yield in evaluation of children with
developmental delay and/or dysmorphic features, especially in countries with limited resources.
 2018 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction tion 1(FMR1) gene testing, methyl-CpG binding protein 2(MeCP2)Global developmental delay (GDD) represents a measurable lag
in a young child’s achievement of developmental milestones com-
pared to age matched children. Children aged less than six years
are considered to have global developmental delay (GDD) if their
performance was more than two standard deviations (SDs) below
age-matched peers in two or more developmental domains [1–
3]. It is considered a common problem, affecting 1–3% of children
[4]. The American Academy of Neurology and the Child Neurology
Society guidelines regarding evaluation of GDD clarified that sev-
eral diagnostic tests had a greater than 1% yield. These tests include
Giemsa-banded (G-banded) karyotyping, fragile X mental retarda-gene testing in girls with moderate to severe impairment, sub-
telomeric fluorescence in situ hybridization (StFISH) testing, neu-
roimaging and assessments for visual and hearing deficits.
Genetic and metabolic testing were highlighted during the genetic
era [5]. There are numerous and heterogeneous conditions causing
GDD, with etiological yields ranging from 10 to 80% depending on
variations in population characteristics, classification and diagnos-
tic facilities available, such as genetic and imaging technology
[6,7]. Retrospective and prospective studies found a yield of around
50% and the conditions were, in order of decreasing frequency; (1)
genetic syndromes/chromosomal anomalies, (2) intrapartum
asphyxia, (3) cerebral dysgenesis, (4) severe psychosocial depriva-
tion and (5) ante-natal toxin exposure [5–7]. Conventional kary-
otyping using microscopy techniques or banding can initially
detect duplication and recurrent deletions, which lead to many
cases of mental retardation (MR). G-banding karyotype analysis
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somes in many laboratories worldwide and has an estimated yield
of at 3% (excluding Down syndrome and other recognizable chro-
mosomal syndromes) [8,9]. G-bands by trypsin using Giemsa
(GTG), is performed by chromosome digestion with proteolytic
enzymes, followed by Giemsa staining, leading to a characteristic
pattern of light and dark bands (G bands) for each chromosome
pair detected under a microscope [8]. Although karyotyping has
been accepted as the standard for genetic assessment of children
with GDD, it lacks the ability to capture chromosomal imbalances
smaller than five to 10 Mb [10–12]. Smaller chromosomal gains
and losses can be detected by fluorescence in situ hybridization
(FISH) and multiplex ligation-dependent probe amplification.
However, these techniques can be utilized only for a specific clin-
ical suspicion or for the analysis of subtelomeric regions of the gen-
ome known to be frequently affected in developmentally impaired
children [13]. There are demanding needs for accurate diagnosis
and there is wide use of conventional karyotyping in our locality,
in addition to few studies being conducted to address the value
and yield of karyotyping in children with global developmental
delay and/or dysmorphic features in Upper Egypt.2. Aim of the work
This work aimed to determine the yield of karyotyping and to
explore the pattern of chromosomal abnormalities in children with
GDD and/or dysmorphic features in Sohag University Hospital,
Upper Egypt.3. Subjects and methods
3.1. Study design
This study was both prospective and retrospective, observa-
tional hospital based study done in the Pediatric Neurology Clinic,Fig. 1. Scheme oPediatric Department, Sohag University Hospital, Upper Egypt,
over a one year period from January 2016 through December
2016. Informed consent of the parents of the children coming for
follow up was taken prior to conducting this research and was
approved by the Faculty of Medicine, Sohag University Ethics Com-
mittee. In addition, it was carried out in accordance with The Code
of Ethics of The World Medical Association (Declaration of Hel-
sinki) for experiments in humans.
3.2. Patients
This study included all children who presented to us with global
developmental delay, dysmorphic features, hypotonia and or intel-
lectual disability and had abnormal karyotyping in the last eight
years. For those children still coming for follow up in our clinic,
data was taken from the patients and their parents, whereas for
those who missed follow up data was extracted from the patient’s
files. Exclusion was done for cases that did not have karyotyping;
meanwhile, those with normal findings were used only as a refer-
ence for positive yield (Fig. 1).
3.3. Methods
The results of karyotyping were reviewed and confirmed. In all
cases, routine GTG (Giemsa banding technique) karyotyping was
done, in five cases FISH test (fluorescence in situ hybridization)
was performed, while in only three cases, studying for fragile-X
syndrome was conducted. Karyotyping was requested previously
for the patients as part of their diagnostic evaluation.
Patients data were reviewed and clinical history including age,
sex, birth order, consanguinity, family history, perinatal, neonatal
and developmental history were collected. History of behavioral
problems like hyperactivity, aggression and autistic features were
also included.
The details of patients examinations took into account general
look and the presence of dysmorphic features (slanting eyes,f the study.
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in addition to simian crease, clinodactyly and overlapping of fin-
gers, as well as anthropometric measurements and a systemic
and through neurological examination (including muscle tone
and stretch reflexes).
Furthermore, the results of other investigations done for the
patients, such as computed tomography (CT) and magnetic reso-
nance imaging (MRI) of the brain and electroencephalography
(EEG) were included.3.4. Statistical analysis
The data was subjected to statistical analysis and tabulation
using SPSS version 18, then the results were presented to fulfill
the objectives of the study.Table 1
Distribution of cases according to karyotyping (n = 646).
No. (%) Classifications of chromosomal abno









of chromosome 21 and X chromoso
Trisomy 18, Edwards syndrome
Trisomy 13, Patau syndrome
[46, XX, der(13;14), +13]
Structural chromosomal abnormalit
chromosome
Fragile-X Syndrome [46, XY, Fra (X)
Total cases of normal karyotype 251 (38.9%)
Fig. 2. A: Translocation Patau syndrome[46,XX,der(13;14),+13]. B: Klinefelter/Down syn
Klinefelter syndrome[47,XXY]. F: Turner syndrome [45, X0]. G: Foot non pitting oedem
syndrome. I: Fragile X syndrome [46,XY, Fra(X)(q27.3)].4. Results
The total number of the patients enrolled in this study with
abnormal karyotyping was 395 (61.1%) out of 646 patients sub-
jected to karyotyping. The vast majority of chromosomal abnor-
malities were trisomy 21-Down syndrome as it was detected in
364 patients (92.2%), and free trisomy 21 (non-disjunction) sub-
type was the most common as it was found in 356 patients
(97.8%), followed by translocations and mosaic trisomy 21 in four
patients (1.1%) each. Interestingly, we found one case (0.25%) of
mixed abnormality; double aneuploidies involving chromosome
21 and X chromosomes(48 XXY, +21) (Klinefelter/Down syn-
drome). Other chromosomal trisomies were: Edward syndrome
as reported in one case (0.25%) and translocation Patau syndrome
was also detected in one case (0.25%) (Table 1) (Fig. 2).
Sex chromosome abnormalities were defined in eight cases
(2.0%); of which Turner syndrome was the most common asrmalities, No. (%) Subtypes of chromosomal abnormalities, No(%)






Klinefelter syndrome, two cases
(47, XXY), and one case (49, XXXXY)
3 (37.5%)
Turner syndrome, 45, X0 4 (50.0%)






ies and marker 19 (4.8%)
(q27.3)] 1 (0.25%)
drome[48, XXY, +21]. C: Extra XX chromosome [48,XXXX]. D, E: Two patients with
a in a patient with Turner syndrome. H: Neck webbing in a patient with Turner
Table 2
Distribution of structural chromosomal abnormalities and marker chromosome (n = 19).
Chromosome Chromosomal aberrations No. (%)
Ch 1 Inversion of chromosome 1[46, XY, inv (1) (p34.2q42)] 1(5.26%)
Ch 3 Deletion at chromosome 3 [46, XX, del(3) (3p25-26)] 1(5.26%)
Ch 4 Deletion of long arm of chromosome 4 [46, XX, del(4)(q25-q27)] 1(5.26%)
Ch 5 Deletion in chromosome 5 [46, XX, del(5)(p 15.2)] 1(5.26%)
Deletion of short arm of chromosome 5 -5P syndrome [46, XX, del(5)(5p14-5p15.1)] 1(5.26%)
Ch 6 Abnormal chromosome 6 short arm [46, XX, abnormal(6)(p)] 1(5.26%)
Ch 7 Deletion of long arm of chromosome 7 (William Syndrome) [46, XY, del(7)(q)] 1(5.26%)
Ch 7,9 Chromosome 7 and 9 reciprocal translocation[46, XX, t(7,9)] 1(5.26%)
Ch 9 Abnormal chromosome 9, additive material- Piere Rubin Sequence [46, XY, add(9)] 1(5.26%)
Ch 11 Abnormal chromosome 11 (addition material) [46, XY, add(11)(9.25)] 1(5.26%)
Ch 15 Abnormal chromosome 15 with added chromosome material in its short arm [46, XY, add(15)(p)] 1(5.26%)
Deletion in long arm of chromosome 15 (Prader Willi syndrome) [46, XY, del(15)(q)] 1(5.26%)
Ch 18 Deletion of short arm of chromosome 18[46, XX, del(18)(p11.2)] 1(5.26%)
Deletion in chromosome 18 [46, XX,del(18)(q22)] 1(5.26%)
Ch 21 Addition at chromosome 21 [46, XY, add(21)(21q22)] 1(5.26%)
Ch 22 Chromosome 22 micro deletion [46, XY, del(22)] 1(5.26%)
Ch Y Deletion of long arm of Y chromosome [ 46, XY, del(Y)(q)] 1(5.26%)
Marker Chromosome Marker chromosome female [47 XX, + marker] 1(5.26%)
Marker chromosome male [47 XY, + marker] 1(5.26%)
Abbreviations inv: inversion, del: deletion, t: translocation, add: addition, p: short arm, q: long arm.
Fig. 3. A: Addition at chromosome 15 [46, XY, Add(15)(p 13)]. B: Deletion in chromosome 18 long arm [46,XX,del(18)(q22)]. C: Inversion of chromosome 1 [46,XY,inv(1)
(p34.2q42)]. D: Deletion of short arm of chromosome 18[46, XX, del(18)(p11.2)]. F: Addition at chromosome 11[46, XY, add(11)(9.25)]. G: Reciprocal translocation between
chromosome 7 and chromosome 9 [46,XX,t(7,9)(q11.2-p23)]. H,I: Female child with marker chromosome [47,XX, + mar]. J,K: Male child with marker chromosome
[47,XY, + mar].
256 A.A. Sadek, M.A. Mohamed / The Egyptian Journal of Medical Human Genetics 19 (2018) 253–259reported in four cases (50.0%), followed by Klinefelter syndrome in
three cases (37.5%) and, lastly, an extra X chromosome in one
female case (12.5%) (Table 1) (Fig. 2).
Structural chromosomal abnormalities and marker chromo-
some were detected in 19 cases (4.8%), the most common was
chromosome five deletion of short arm, chromosome 15 and chro-
mosome 18 abnormalities, in addition to marker chromosome,
were found in two cases (10.5%) each (Table 2) (Fig. 3). Testing
for fragile-X syndrome was positive in one case (0.25%) (Table 1)
(Fig. 2).
The positive yield of karyotyping in children with developmen-
tal delay and dysmorphic features including classic Down features
was 61.1%. However, with exclusion of Down syndrome and other
suspected trisomies from cases the positive yield was 7.4%.
The mean age of presentation in our study was 24.7 ± 32.1(SD)
months, with an age range from one month to 204 months. There
were 243 (61.5%) males and 152 (38.5%) females. The most preva-
lent condition was global developmental delay in half of the
patients (205/51.9%), followed by dysmorphic features in 95patients (24.1%). The 1st child in birth order was the most com-
monly affected, however other birth orders were reported. Consan-
guinity was reported in 186 (47.0%) patients, while positive family
history of similar conditions or neurological problems was
reported in 40 patients (Table 3).
Regarding developmental evaluation: 302 (76.5%) patients had
delayed motor development, 385 (97.5%) patients had delayed
speech, while 307 (77.7%) patients had delayed social development
and, lastly, hyperactivity and autistic features were reported in 33
(8.4%) patients (Table 3).
Neurological evaluation showed that the majority of cases had
microcephaly, with a mean head circumference of 41.4 ± 4.7 (SD)
cm and a range from 29 cm to 53 cm. Hypotonia was reported in
315 (79.7%) patients while hypertonia was reported in five (1.3%)
patients, finally normal tone was found in 75 (19%) patients
(Table 4).
Computed tomography (CT) of the brain was done in 41
patients; 16 (39.0%) of them had normal findings, 20 (48.8%)
patients had brain atrophy; while three patients had white matter
Table 3
Socio-demographic data and clinical presentation of the studied cases (n = 395).
Variable Abstract statistic
Age of presentation (months)
Mean (SD) 24.7 (32.1)






DLD and Hyperactivity 78 (19.7%)
Dysmorphic feature 95 (24.1%)
Others(poor feeding, head nodding) 17 (4.3%)
Birth order
Mean (SD) 3.88 (2.4)

















Hyperactivity and autistic features 33 (8.4%)
Abbreviations SD: standard deviation, GDD: global developmental delay, DLD:
delayed language development.
Table 4
Neurological evaluation and investigations done for the studied




Mean (SD) 41.4 (4.7)








Brain atrophy 20 (48.8%)
White matter disease 3 (7.3%)
Corpus callosum agenesis 2 (4.9%)
Not done 354 (89.6%)
MRI brain
Normal 1 (7.6%)
Brain atrophy 7 (53.8%)
White matter disease 4 (31%)
Corpus callosum agenesis 1 (7.6%)
Not done 382 (96.7%)
EEG finding
Normal 3 (11.5%)
Epileptic abnormalities 18 (69.3%)
Hypsarrhythmia 5 (19.2%)
Not done 369 (93.4%)
Abbreviations SD: standard deviation, CT: computed tomogra-
phy, MRI: magnetic resonance imaging, EEG:
electroencephalogram.
A.A. Sadek, M.A. Mohamed / The Egyptian Journal of Medical Human Genetics 19 (2018) 253–259 257changes (7.3%). Magnetic resonance imaging (MRI) of the brain was
done in 13 patients, brain atrophy was most commonly reported,
in seven patients (53.8%). Seizure disorders were found in 10
patients (2.5%), half of them had epileptic spasms (50.0%). Elec-
troencephalography was done on 26 patients; 18 (69.3%) of them
had epileptic recording, while a specific hypsarrhythmia pattern
was found in five patients (19.2%).
5. Discussion
The need for reliable clinical genetic testing in evaluating
patients with developmental delay (DD), mental retardation (MR)
and autism spectrum disorders (ASD) with unclear etiology is para-
mount [14,15].
This study was conducted in a region of limited resources in
Upper Egypt, exploring the pattern of chromosomal disorders
and yield of conventional karyotyping over the last eight years in
children with developmental problems at Sohag University
Hospital.
In our study, males were predominant (61.5% vs 38.5%) and this
agreed with other studies [7,8]. They found affected males at 74%
and 61.2%, respectively. The mean age of presentation of our cases
was 24.7 months, while in the study of Srour et al. [7] the mean age
was 33.6 months and was 30 months in another study [16].
The positive yield of karyotyping in our series was 61.1% (395
out of 646). This percentage was high compared to other studies.
However, with exclusion of Down syndromes and other known tri-
somies, the positive yield was 7.4%. This was still higher than other
studies [9,17], which concluded that the diagnostic yields of con-
ventional cytogenetics and fragile-X syndrome testing in patients
with developmental delay/mental retardation (DD/MR) is below
3% and 1.2% respectively. However, the reported yield was about
4%, such as in the studies done by many researchers with a range
from (2.9–11.7%) [6,18–24]. On the other hand, higher yields were
obtained that could reach 18.6% (6.7–50%), as in other studies [21–
23].
Overall, in children with global developmental delay, the causes
and risk factors are heterogeneous, so there are marked variations
in the yield. Thus etiological yield could reach 50% as reported in
two studies [19,25]; they found chromosomal abnormalities in
11.7% and fragile-X syndromes in 3.3%.
In another study of developmental delay, etiological yield was
found in 41.6%, chromosomal abnormalities were found in 28% of
them, while fragile-X syndromes were found in 6% [19]. Also, other
researchers [26] found etiological diagnosis in children with GDD
in 63.3% and chromosomal abnormalities were found in 10%. In
the study done by Shevell et al. [6], an etiology was found in
61.97% and chromosomal abnormalities accounted for 77% of the
cases. Furthermore, in a study done by Srour et al. [7] on patients
with global developmental delay, the etiologic yield was also
defined as 40% overall and 55% in the absence of autistic features.
Focusing on dysmorphic features, they could ascertain an etiologic
yield in 52.4% of cases [7]. In another study [16], they found defi-
nite etiology for GDD in 54.1% and karyotyping yield was 12.5%,
all of them were Down syndrome. In a recent study [8], the yield
of karyotyping was 8.4%.
In our study, Down syndrome was detected in 92.2%, sex chro-
mosome abnormalities in 2.0% and structural chromosomal abnor-
malities in 14.8%. These findings were relatively similar to other
researchers [27] working on female mental retardation series
who found chromosomal abnormalities in 24%, of which Down
syndrome was detected in 83.33% and structural abnormalities in
13.88%, while Turner syndrome was identified in 2.77%. Another
study done by Behjati et al. [28] on patients with idiopathic mental
retardation from consanguineous marriages, found ten patients
(3.10%) showed chromosome abnormalities, the abnormalities
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in three patients (0.93%), 2) presence of a high percentage of pro-
meta phase/prophase chromosome spreads, with twisted, curly
and poor banding quality and 3) autosomal structural
abnormalities.
Furthermore, in a study done by Teixeira et al. [8], the yield of
karyotyping in patients with mental retardation was: 67.8% of
cases with abnormal karyotyping had structural abnormalities,
29% had numerical abnormalities, sex chromosome abnormalities
represented 55.55%, while trisomy 21 was detected in 33.33%.
In this study, we found many structural abnormalities (inver-
sion, deletion, addition and reciprocal translocation, in addition
to marker chromosome) affecting many chromosomes (Table 2)
and this was comparable to a similar study which identified break-
points involving many chromosomal regions [8]. Also, another
researcher found four patients (1.24%) with unbalanced structural
chromosome abnormalities, all of which were unbalanced segrega-
tion products of parental balanced rearrangements [28].
Interestingly, we reported two cases of marker chromosome,
one male and one female, their main presentation was global
developmental delay and dysmorphic features. A comparable
study [8], reported three cases with additional marker chromo-
somes of unknown origin, two of which were mosaic marker
chromosomes.
In this work, the most common numerical (also autosomal)
chromosomal aberration (aneuploidy) was Down syndrome, as
detected in 92.2%. It is considered the most common genetic cause
of intellectual disability [29] and moderate mental retardation
[17,30].
We identified four patients with Klinefelter syndrome, one of
them had double aneuploidies involving chromosome 21 and X c
hromosomes(48XXY,+21)(Klinefelter/Down syndrome), two of
them had severe mental retardation, marked neurological deficit,
intractable seizures and autistic features. The estimated frequency
of this disorder is between 1:500 and 1:1000 live births. Patients
with Klinefelter syndrome usually have delayed auditory process-
ing, language dysfunction and, in rare cases, severe intellectual
retardation [31]. Similarly, we reported four cases with Turner syn-
drome; those patients, in addition to the unique physical charac-
teristics of this syndrome, have a non-verbal IQ significantly
lower than their verbal IQ and commonly require educational
intervention for learning disabilities [32,33].
Surprisingly, we reported two cases (brother of a Klinefelter
case and sister of an extra X syndrome case) had nearly similar
degree of mental retardation and developmental delay, but had
normal karyotyping. Comparable results were obtained by Behjati
et al. [28].
Epilepsy was reported in 2.5% of the patients; the most common
type was epileptic spasms (50%), and the majority of them (four
cases/80%) were Down syndrome. This was in accordance with
the previous studies concluding that West syndrome constitutes
the most frequent of all seizure types in infants with Down syn-
drome [34–37].
Although our study showed high diagnostic yield for G-banded
karyotyping, reaching 61.1% and 7.4% after exclusion of Down syn-
dromes and other known trisomies, there are limitations attributed
to the recent assumption that chromosomal microarray (CMA) is
increasingly utilized for genetic testing of children with unex-
plained developmental delay/intellectual disability (DD/ID), aut-
ism spectrum disorders (ASD) or multiple congenital anomalies
(MCA). And that CMA gives a much higher diagnostic yield (15–
20%) for genetic testing of these patients than a G-banded kary-
otype (3%, excluding Down syndrome and other recognizable
chromosomal syndromes), because of its higher sensitivity for sub-
microscopic deletions and duplications [9].6. Conclusions
G-banded karyotyping is a useful tool with reasonable yield in
evaluation of children with developmental delay and or dysmor-
phic features, especially in countries with limited resources. Tri-
somy 21 (Down syndrome) was the most common chromosomal
abnormality encountered in Sohag University Hospital, followed
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